Clinical trial
Can Discharge Via an Intermediate Care Unit Prevent Aggravation of Disease and Loss of Functionality, Without Increasing the Level of Cost? A Controlled Observational Study
NCT01706744 is registered in ClinicalTrials.gov with Norwegian University of Science and Technology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Can Discharge Via an Intermediate Care Unit Prevent Aggravation of Disease and Loss of Functionality, Without Increasing the Level of Cost? A Controlled Observational Study
- Lead sponsor
- Norwegian University of Science and Technology
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 28, 2010
- Completion date
- December 31, 2013
- Enrollment
- 328 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
aged, patients